Liver disease in Crohn's disease. A study of 100 consecutive patients.
D000469:Alkaline Phosphatase / Q000097:blood; D000486:Allergy and Immunology; D000686:Amyloidosis / Q000150:complications; D001663:Bilirubin / Q000032:analysis; D001803:Blood Transfusion; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy; D003424:Crohn Disease / Q000150:complications* / Q000503:physiopathology; D005234:Fatty Liver / Q000150:complications; D005350:Fibroma / Q000150:complications; D006099:Granuloma / Q000150:complications; D006801:Humans; D007249:Inflammation / Q000150:complications; D007565:Jaundice / Q000150:complications; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000150:complications* / Q000503:physiopathology; D008111:Liver Function Tests; D009708:Nucleotidases / Q000097:blood; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis; D013448:Sulfobromophthalein
D012709:Serum Albumin; D012712:Serum Globulins; D013448:Sulfobromophthalein; D009708:Nucleotidases; D000469:Alkaline Phosphatase; D001663:Bilirubin